On the public citation graph

The gatekeepers of hES cell products

https://doi.org/10.1038/nbt0705-817
0 signed · 21 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1038/435272aopenalex-snapshot
Licensing fees slow advance of stem cells

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.1529602openalex-extracted
Network Effects in Biology
inferred← citeshttps://doi.org/10.1007/978-3-642-32841-1_2openalex-snapshot
The Limits of Patentability: Stem Cells
inferred← citeshttps://doi.org/10.1007/s11673-006-9005-6openalex-snapshot
Proliferating Patent Problems with Human Embryonic Stem Cell Research?
inferred← citeshttps://doi.org/10.1016/b978-0-12-381422-7.10062-8openalex-snapshot
US Stem Cell Research Policy
inferred← citeshttps://doi.org/10.1016/b978-0-12-809880-6.00075-8openalex-snapshot
US Stem Cell Research Policy
inferred← citeshttps://doi.org/10.1016/b978-012369410-2.50082-6openalex-snapshot
US Stem Cell Research Policy
inferred← citeshttps://doi.org/10.1016/j.tibtech.2006.06.010openalex-snapshot
Governing stem cell research in California and the USA: towards a social infrastructure
inferred← citeshttps://doi.org/10.1038/474579dopenalex-snapshot
More at stake in stem-cell patents
inferred← citeshttps://doi.org/10.1038/nbt0406-411openalex-snapshot
The paths around stem cell intellectual property
inferred← citeshttps://doi.org/10.1038/nbt0407-419openalex-snapshot
The global stem cell patent landscape: implications for efficient technology transfer and commercial development
inferred← citeshttps://doi.org/10.1057/palgrave.jcb.3040158openalex-snapshot
Stem cell patenting
inferred← citeshttps://doi.org/10.1093/humrep/dep369openalex-snapshot
Patenting human pluripotent cells: balancing commercial, academic and ethical interests
inferred← citeshttps://doi.org/10.1098/rsif.2010.0351.focusopenalex-snapshot
Regenerative nanomedicines: an emerging investment prospective?
inferred← citeshttps://doi.org/10.1098/rstb.2006.2018openalex-snapshot
Neurodegeneration and cell replacement
inferred← citeshttps://doi.org/10.1111/j.1468-0009.2009.00575.xopenalex-snapshot
Columbia University's Axel Patents: Technology Transfer and Implications for the Bayh‐Dole Act
inferred← citeshttps://doi.org/10.1111/j.1747-1346.2008.00161.xopenalex-snapshot
Human Embryonic Stem Cell Research in the United States: Some Policy Options for Industry Development
inferred← citeshttps://doi.org/10.1634/stemcells.2005-0452openalex-snapshot
A Comparison of NIH‐Approved Human ESC Lines
inferred← citeshttps://doi.org/10.2217/17460751.1.3.313openalex-snapshot
Commercializing Stem Cells: the Road Ahead
inferred← citeshttps://doi.org/10.2217/17460751.3.4.597openalex-snapshot
Stem Cell Innovation in the USA: The Benefits of the Minimal State
inferred← citeshttps://doi.org/10.34122/jip.2008.06.3.1.153openalex-snapshot
An Introductive Study regarding Material Transfer Agreement
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.